[Cerebral side effects in metoclopramide (Cerucal) administration].
D000293:Adolescent; D000978:Antiparkinson Agents / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D005260:Female; D006801:Humans; D008787:Metoclopramide / Q000009:adverse effects*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced
D000978:Antiparkinson Agents; D008787:Metoclopramide
Zerebrale Nebenwirkung bei Metoclopramid- (Cerucal-) Medikation.